These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 884122)

  • 21. Amino acid composition of polypeptides from influenza virus particles.
    Laver WG; Baker N
    J Gen Virol; 1972 Oct; 17(1):61-7. PubMed ID: 5084454
    [No Abstract]   [Full Text] [Related]  

  • 22. [Purification and study of influenza virus neuraminidases].
    Zaĭdes VM; Selimova LM; Dotsenko GN; Zhdanov VM
    Vopr Virusol; 1981; (6):692-7. PubMed ID: 7336693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification of neuraminidases from Vibrio Cholerae, Clostridium Perfringens and influenza virus by affinity chromatography.
    Cuatrecasas P; Illiano G
    Biochem Biophys Res Commun; 1971 Jul; 44(1):178-84. PubMed ID: 4330046
    [No Abstract]   [Full Text] [Related]  

  • 24. A fluorometric procedure for measuring the neuraminidase activity: its application to the determination of this activity in influenza and parainfluenza viruses.
    Cabezas JA; Reglero A; Hannoun C
    Anal Biochem; 1983 May; 131(1):121-6. PubMed ID: 6311045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NEURAMINIDASES AND INFLUENZA VIRUS INFECTION IN EMBRYONATED EGGS.
    JOHNSON CA; PEKAS DJ; WINZLER RJ
    Science; 1964 Mar; 143(3610):1051-2. PubMed ID: 14107434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of recombinant protein-based influenza vaccine. Expression and affinity purification of H1N1 influenza virus neuraminidase.
    Dalakouras T; Smith BJ; Platis D; Cox MM; Labrou NE
    J Chromatogr A; 2006 Dec; 1136(1):48-56. PubMed ID: 17046775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of recombination in the production of influenza vaccine strains.
    McCahon D; Beare AS; Schild GC; Hall TS
    Postgrad Med J; 1973 Mar; 49(569):195-9. PubMed ID: 4802647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuraminidase of influenza virus].
    Cabezas JA; Cabezas M; Calvo P; Martín J; Pérez N; Hueso P; Rodrigo M; Reglero A
    Rev Esp Fisiol; 1982; 38 Suppl():81-6. PubMed ID: 7146596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins.
    Brady MI; Furminger IG
    J Hyg (Lond); 1976 Oct; 77(2):161-72. PubMed ID: 1068195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine.
    Kilbourne ED; Schulman JL; Schild GC; Schloer G; Swanson J; Bucher D
    J Infect Dis; 1971 Nov; 124(5):449-62. PubMed ID: 5115669
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiviral activity of antiserum specific for an influenza virus neuraminidase.
    Kilbourne ED; Laver WG; Schulman JL; Webster RG
    J Virol; 1968 Apr; 2(4):281-8. PubMed ID: 4911843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.
    Yen HL; Herlocher LM; Hoffmann E; Matrosovich MN; Monto AS; Webster RG; Govorkova EA
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4075-84. PubMed ID: 16189083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of neuraminidase in Arthrobacter and its purification by affinity chromatography.
    Uchida Y; Tsukada Y; Sugimori T
    J Biochem; 1977 Nov; 82(5):1425-33. PubMed ID: 591509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presence of two neuraminidases in an influenza virus.
    Arora DJ; Hill-Schubert J; Vincent L
    Can J Microbiol; 1980 Feb; 26(2):243-9. PubMed ID: 6157463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virions.
    Crawford CR; Mukhlis FA; Jennings R; Oxford JS; Hockley DJ; Potter CW
    Vaccine; 1984 Sep; 2(3):193-8. PubMed ID: 6531961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physiochemical properties of purified and virion neuraminidases of the influenza B viruses].
    Brydak L; Liubotseva OV; Iakhno MA; Zakstel'skaia LIa
    Vopr Virusol; 1987; 32(2):156-9. PubMed ID: 3604184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of influenza neuraminidase in baculovirus-infected cells.
    Mather KA; White JF; Hudson PJ; McKimm-Breschkin JL
    Virus Res; 1992 Nov; 26(2):127-39. PubMed ID: 1476004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative enzyme kinetics of influenza neuraminidases with the synthetic substrate methoxyphenylneuraminic acid.
    Sedmak JJ; Grossberg SE
    Virology; 1973 Dec; 56(2):658-61. PubMed ID: 4757702
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of sialidase from an influenza A (H3N2) virus strain: kinetic parameters and substrate specificity.
    França de Barros J; Sales Alviano D; da Silva MH; Dutra Wigg M; Sales Alviano C; Schauer R; dos Santos Silva Couceiro JN
    Intervirology; 2003; 46(4):199-206. PubMed ID: 12931027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Synthesis and properties of an affinity adsorbent for purifying neuraminidases of varying origins].
    Poltorak AN; Martiushin SV; Pasechnik VA
    Prikl Biokhim Mikrobiol; 1985; 21(3):365-71. PubMed ID: 2864684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.